Question 1

What is my UGT1A1 genotype, and how does it affect my treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the An Observational Study of CPT-11 Based Regimens and UGT1A1 Genotypes in Metastatic Colorectal Cancer (mCRC) clinical trial (NCT01039506). Contact the study team or your healthcare provider for specific answers.

Question 2

How do the CPT-11 based regimens compare to other treatments I might consider?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the An Observational Study of CPT-11 Based Regimens and UGT1A1 Genotypes in Metastatic Colorectal Cancer (mCRC) clinical trial (NCT01039506). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of the CPT-11 treatments being studied?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the An Observational Study of CPT-11 Based Regimens and UGT1A1 Genotypes in Metastatic Colorectal Cancer (mCRC) clinical trial (NCT01039506). Contact the study team or your healthcare provider for specific answers.

Question 4

How will my participation in this study be monitored and what tests will I need?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the An Observational Study of CPT-11 Based Regimens and UGT1A1 Genotypes in Metastatic Colorectal Cancer (mCRC) clinical trial (NCT01039506). Contact the study team or your healthcare provider for specific answers.

Question 5

What are the logistics of participating in this study, such as visit frequency and location?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the An Observational Study of CPT-11 Based Regimens and UGT1A1 Genotypes in Metastatic Colorectal Cancer (mCRC) clinical trial (NCT01039506). Contact the study team or your healthcare provider for specific answers.

What this study is about